Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03957902 |
|
Recruitment Status :
Recruiting
First Posted : May 21, 2019
Last Update Posted : May 21, 2019
|
Sponsor:
Instituto de Investigación Sanitaria Aragón
Collaborators:
Instituto de Salud Carlos III
G. d'Annunzio University
Hospital Clínico Universitario Lozano Blesa
Information provided by (Responsible Party):
Ángel Lanas Arbeloa, Instituto de Investigación Sanitaria Aragón
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2020 |
| Estimated Study Completion Date : | May 2020 |